Literature DB >> 14678976

Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.

Johann Soret1, Mathieu Gabut, Cecile Dupon, Glenda Kohlhagen, James Stévenin, Yves Pommier, Jamal Tazi.   

Abstract

DNA topoisomerase I (Topo I) specifically phosphorylates arginine-serine-rich (SR proteins) splicing factors and is potentially involved in pre-mRNA-splicing regulation. Using a Topo I-deficient murine B lymphoma-derived subclone (P388-45/C) selected for its resistance to high dosage of the antitumor drug camptothecin, we show that Topo I depletion results in the hypophosphorylation of SR proteins and impairs exonic splicing enhancer (ESE)-dependent but not constitutive splicing. The Affymetrix GeneChip system analysis revealed that several alternatively spliced genes, characterized by small exons and large introns, are down-regulated in Topo I-deficient cells. Given that ectopic expression of green fluorescent protein-Topo I fusion in Topo I-deficient cells restores both wild-type phosphorylation of SR proteins and ESE-dependent splicing, we conclude that Topo I-mediated phosphorylation plays a specific role in ESE-regulated splicing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678976

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

2.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

Review 3.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.

Authors:  Johann Soret; Nadia Bakkour; Sophie Maire; Sébastien Durand; Latifa Zekri; Mathieu Gabut; Weronika Fic; Gilles Divita; Christian Rivalle; Daniel Dauzonne; Chi Hung Nguyen; Philippe Jeanteur; Jamal Tazi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

5.  Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways.

Authors:  Jérôme Barbier; Martin Dutertre; Danielle Bittencourt; Gabriel Sanchez; Lise Gratadou; Pierre de la Grange; Didier Auboeuf
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

6.  Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission.

Authors:  Olivier Sordet; Abby Goldman; Christophe Redon; Stéphanie Solier; V Ashutosh Rao; Yves Pommier
Journal:  J Biol Chem       Date:  2008-06-13       Impact factor: 5.157

7.  Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription.

Authors:  Sandie Tuduri; Laure Crabbé; Chiara Conti; Hélène Tourrière; Heidi Holtgreve-Grez; Anna Jauch; Véronique Pantesco; John De Vos; Aubin Thomas; Charles Theillet; Yves Pommier; Jamal Tazi; Arnaud Coquelle; Philippe Pasero
Journal:  Nat Cell Biol       Date:  2009-10-18       Impact factor: 28.824

8.  Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.

Authors:  S T Workenhe; T Ketela; J Moffat; B P Cuddington; K L Mossman
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

9.  Hyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I.

Authors:  Olivier Sordet; Stéphane Larochelle; Estelle Nicolas; Ellen V Stevens; Chao Zhang; Kevan M Shokat; Robert P Fisher; Yves Pommier
Journal:  J Mol Biol       Date:  2008-06-17       Impact factor: 5.469

10.  Network-assisted protein identification and data interpretation in shotgun proteomics.

Authors:  Jing Li; Lisa J Zimmerman; Byung-Hoon Park; David L Tabb; Daniel C Liebler; Bing Zhang
Journal:  Mol Syst Biol       Date:  2009-08-18       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.